The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results